SMTL ID : 1y1d.1

Crystal structure of transthyretin in complex with iododiflunisal

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

homo-tetramer

Ligands

4 x FHI: 2',4'-DIFLUORO-4-HYDROXY-5-IODO-1,1'-BIPHENYL-3-CARBOXYLIC ACID(Non-covalent)

FHI.1: 11 residues within 4Å: Chain A: K.15, L.17, L.110, S.117 Chain C: K.15, A.108, A.109, L.110, T.119, V.121 Ligands: FHI.3 10 PLIP interactions: 5 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:A.108, C:L.110, C:T.119, A:L.17, A:L.110 Water bridges: C:K.15, A:K.15, A:K.15 Salt bridges: C:K.15, A:K.15 FHI.2: 11 residues within 4Å: Chain B: K.15, L.17, L.110, S.117 Chain D: K.15, T.106, A.108, L.110, T.119, V.121 Ligands: FHI.4 8 PLIP interactions: 3 interactions with chain B, 5 interactions with chain D Hydrophobic interactions: B:L.17, B:L.110, D:A.108, D:L.110, D:T.119 Salt bridges: B:K.15, D:K.15 Halogen bonds: D:T.106 FHI.3: 11 residues within 4Å: Chain A: K.15, A.108, A.109, L.110, T.119, V.121 Chain C: K.15, L.17, L.110, S.117 Ligands: FHI.1 10 PLIP interactions: 5 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:L.17, C:L.110, A:A.108, A:L.110, A:T.119 Water bridges: C:K.15, C:K.15, A:K.15 Salt bridges: C:K.15, A:K.15 FHI.4: 11 residues within 4Å: Chain B: K.15, T.106, A.108, L.110, T.119, V.121 Chain D: K.15, L.17, L.110, S.117 Ligands: FHI.2 8 PLIP interactions: 5 interactions with chain B, 3 interactions with chain D Hydrophobic interactions: B:A.108, B:L.110, B:T.119, D:L.17, D:L.110 Salt bridges: B:K.15, D:K.15 Halogen bonds: B:T.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gales, L. et al., Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor. Biochem.J. (2005)

Release Date

2005-07-26

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence